The Europe urinary catheters market is witnessing steady growth, driven by the increasing prevalence of urinary disorders and an aging population across the region. Valued at USD 1.33 Billion in 2025, the market is projected to grow at a CAGR of 5.30% during 2026–2035, reaching USD 2.23 Billion by 2035. Urinary catheters, essential for patients with bladder dysfunction, post-surgical care, or chronic conditions, are becoming increasingly critical in both hospital and home care settings.

Key Drivers Fueling Market Growth

Rising Prevalence of Urological Disorders: Conditions such as urinary incontinence, neurogenic bladder, and post-operative urinary retention are driving demand.

Aging Population: Europe’s growing elderly population contributes to higher catheter utilization.

Technological Advancements: Innovations in materials, coatings, and design are improving safety, comfort, and reducing infection risks.

Home Healthcare Expansion: Increased adoption of self-catheterization and home care solutions supports market growth.

Competitive Landscape

The Europe urinary catheters market is highly competitive, with leading medical device companies driving innovation and expanding their product portfolios:

Bard Limited (Becton, Dickinson and Company) & Boston Scientific Corporation – Offering advanced catheter designs and infection-prevention technologies.

Hollister Incorporated & Teleflex Incorporated – Focused on both intermittent and indwelling catheter solutions for patient comfort.

Clinisupplies Ltd, Medtronic PLC & Cook Medical – Developing specialized urology devices and home-care catheter systems.

Convatec Group plc, Coloplast AS & B. Braun Melsungen AG – Providing comprehensive catheter solutions, including coated and hydrophilic catheters.

Amsino International, Inc. – Expanding product lines to include cost-effective and disposable catheter options for clinical and home settings.

Claim your free sample report and review the detailed table of contents.

Market Outlook

The Europe urinary catheters market is expected to maintain steady growth over the next decade, driven by increasing urological healthcare needs and advancements in catheter technologies. Companies investing in R&D, patient-centric designs, and infection-control solutions are likely to capture significant market share. With rising awareness of home healthcare and self-catheterization, the market is set to see sustained expansion, improving patient care and quality of life across Europe.